Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$244.67 USD

244.67
11,341,591

-1.11 (-0.45%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $244.50 -0.17 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (243 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Christopher Vargas headshot

Buy CVS Health (CVS) Ahead of Q2 Earnings?

by Christopher Vargas

CVS Health (CVS) will be reporting their second quarter before the opening bell on Wednesday.

Zacks Equity Research

Community Health's (CYH) Q2 Loss Widens, Revenues Fall Y/Y

by Zacks Equity Research

Community Health's (CYH) second-quarter results suffer due to lower admissions.

Zacks Equity Research

Tenet Healthcare (THC) Q2 Earnings Top Estimates & Rise Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) second-quarter earnings gain on the back of its Hospital and Other segment and volume growth.

David Borun headshot

Trade and Currency Concerns Put Pressure on Equities

by David Borun

A busy week of data and a Fed meeting was dominated by China trade issues

Zacks Equity Research

Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) second-quarter earnings gain traction from improved revenues.

Zacks Equity Research

MEDNAX's (MD) Earnings Beat Estimates in Q2, Decrease Y/Y

by Zacks Equity Research

Mednax's (MD) Q2 gains on revenue growth, partly offset by rise in expenses.

Zacks Equity Research

DaVita (DVA) Earnings Beat, Revenues Miss Estimates in Q2

by Zacks Equity Research

DaVita (DVA) completes divestment of DMG unit to Optum for $4.34 billion.

Zacks Equity Research

Cigna (CI) Beats on Q2 Earnings and Revenues, Guides Up

by Zacks Equity Research

Cigna's (CI) Q2 earnings gain from the acquisition of Express Scripts, completed in December 2018.

Zacks Equity Research

Humana's (HUM) Earnings and Revenues Beat Estimates in Q2

by Zacks Equity Research

Humana's (HUM) second-quarter earnings gain from Medicare Advantage membership growth.

Zacks Equity Research

Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Molina Healthcare's (MOH) second-quarter earnings trump estimates on the back of lower expenses and the Meridian buyout.

Zacks Equity Research

WellCare Health (WCG) Q2 Earnings & Revenues Beat, Rise Y/Y

by Zacks Equity Research

WellCare Health's (WCG) second-quarter earnings gain from improved revenues and higher membership.

Zacks Equity Research

Magellan Health (MGLN) Q2 Earnings Beat Estimates, Down YoY

by Zacks Equity Research

Magellan Healths (MGLN) Q2 earnings reflect a pickup in its business, which should aid its performance in the second half.

Zacks Equity Research

HCA Healthcare (HCA) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

HCA Healthcare's (HCA) second-quarter earnings decline due to escalating expenses.

Zacks Equity Research

Universal Health's (UHS) Q2 Earnings Top Estimates, Rise Y/Y

by Zacks Equity Research

Universal Health's (UHS) second-quarter results gain from its healthy top-line growth.

Swarup Gupta headshot

Dow 30 Stock Roundup: Impressive INTC, MMM, V, UTX Earnings, BA, CAT Disappoint

by Swarup Gupta

The Dow started the week on a high note but trended lower as lackluster earnings numbers flowed in.

Zacks Equity Research

The Zacks Analyst Blog Highlights: UnitedHealth, Citigroup, Honeywell, IBM and Amgen

by Zacks Equity Research

The Zacks Analyst Blog Highlights: UnitedHealth, Citigroup, Honeywell, IBM and Amgen

Zacks Equity Research

Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FTCS

John Blank headshot

How to Win on Stocks with a Trade War

by John Blank

Yes, tariffs slow growth. And yes, rate cuts help stocks.

Zacks Equity Research

Stock Market News For Jul 22, 2019

by Zacks Equity Research

Markets closed lower on Friday after a report stated that Fed officials would reduce the benchmark interest rates in its next meeting by only a quarter percentage points.

Mark Vickery headshot

Top Analyst Reports for UnitedHealth, Citigroup & Honeywell

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Citigroup (C) and Honeywell (HON).

Sweta Killa headshot

Healthcare ETFs in Focus on UnitedHealth's Q2 Earnings

by Sweta Killa

ETFs having the largest allocation to this health insurance giant are in focus post Q2 earnings.

Zacks Equity Research

Strong Economic Data

by Zacks Equity Research

Strong Economic Data

Mark Vickery headshot

Jobless Claims, Philly Fed Strong; Plus Q2: MS, UNH & More

by Mark Vickery

Initial Jobless Claims stayed within a favorable range while Philly Fed posted a big improvement. Plus more Q2 earnings data.

Zacks Equity Research

UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2019

by Zacks Equity Research

Strong segment performance, membership growth and cost control aid UnitedHealth's (UNH) Q2 results.

Zacks Equity Research

UnitedHealth Group (UNH) Beats Q2 Earnings Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 4.05% and -0.12%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?